Department of Medicine
Faculty Profiles by Division

Division of Hematology/Oncology

Faculty Profiles
[Return To Index page]
photo Donald V Woytowitz, MD

Hematology/Oncology

Clinical Assistant Professor of Medicine

Email: woytowitzdv@upmc.edu

Phone: 412-648-6466
Contact
Office: Falk Medical Building
3601 Fifth Avenue
Pittsburgh, PA 15213
 
Phone: 412-648-6466
Fax: 412-864-2663
E-mail: woytowitzdv@upmc.edu
Administrative Assistant:
Linda Mazefsky
Address: 3708 Fifth Avenue
5th Floor, Suite 503
Pittsburgh, PA 15213
Email: mazefskyl2@upmc.edu
Phone: 412-648-6466
Fax: 412-864-2663
Education and Training
Education
Bachelor of Science, University of Maryland, 1983
Doctor of Medicine, University of Maryland, 1987
Training
Internal Medicine Internship & Residency, University of Miami, 1990
Fellowship: Hematology/Oncology, University of Virginia, 1996
Research Interest
Autoimmune hemolytic anemia
ITP
Lupus anticoagulant
Clinical Interest
Myelodysplastic syndrome
Myeloproliferative disorder
Idiopathic thrombocytopenic purpura
Benign Hematology
Low Grade NHL
CLL
Hypercoagulable states
Bleeding disorders
Anemias
Cytopenias
Publications
For my complete bibliography, Click Here.
Selected Publications:
Mertz KJ, Buchanich JM, Washington TL, Irvin-Barnwell EA, Woytowitz DV, Smith RE. Chronic myelogenous leukemia in eastern Pennsylvania: an assessment of registry reporting. Journal of registry management. 2015; 42(1): 9-11.
Lunch TJ, Patel T, Dreisbach L, McCleod M, Heim WJ, Hermann RC, Paschold E, Iannotti NO, Dakhil S, Gorton S, Pautret V, Weber MR, Woytowitz D. Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099. Journal of the American Society of Clinical Oncology. 2010; 28(6): 911-7.
Berenson JR, Yellin O, Woytowitz D, Flam MS, Cartmell A, Patel R, Duvivier H, Nassir Y, Eades B, Abay CD, Hilger J, Swift RA. Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen. European Journal of haematology. 2009; 82(6): 433-9.
Berenson JR, Yellin O, Boccia RV, Flam M, Wong SF, Batuman O, Moezi MM, Woytowitz D, Duvivier H, Nassir Y, Swift RA. Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss. Journal of the American Association for Cancer Research. 2008; 14(19): 6289-95.
Manegold C, Gravenor D, Woytowitz D, Mezger J, Hirsh V, Albert G, Al-Adhami M, Readett D, Krieg AM, Leichman CG. Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide PF-3512676 in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer. Journal of the American Society of Clinical Oncology. 2008; 26(24): 3979-86.

Division Websites

Cardiology

Endocrinology and Metabolism

Gastroenterology, Hepatology and Nutrition

General Internal Medicine

Geriatric Medicine
Hematology/Oncology

Infectious Diseases

Pulmonary, Allergy and Critical Care Medicine

Renal-Electrolyte

Rheumatology and Clinical Immunology

Contact

Department of Medicine
1218 Scaife Hall
3550 Terrace Street
Pittsburgh, PA 15261
Email:  chairoff@pitt.edu
Phone:  412-648-9636
Copyright © 2018 Department of Medicine / University of Pittsburgh School of Medicine
Site maintained by Medicine Technology Services MTS@PITT.EDU